PodimetricsThe company that helps patients with diabetes to prevent serious complications, cooperates with the health, and the employee’s health and wellness platform.
HealthMed aims to integrate Smartmat ‘Podimetrics in its portfolio of the advantages for adult employees, hospitals and municipalities. The company also provides health and mental health programs for employees.
Smartmat’s Smartmat measures the foot temperature for patients at risk and wipes early signs of inflammation that can lead to wounds, amputations and diabetic foot ulcers.
“Our partnership with Healthmed is a strong cooperation, and we are excited to work together to support individuals with complex diabetes who are at greater risk of serious complications,” said Dr. John Bloom, CEO of Podimetrics in a statement.
“We share a common mission to focus on preventing and improving health results. This cooperation aims to achieve this goal together.”
True Webster, the founder of the Healthmed, said that partnership with Podimetrics and its innovative solution to the complex diabetes management will benefit the self -insured employers and improve the sponsorship chain.
“We are looking forward to the positive impact that we can create on health results and the total cost of care,” Webster said in a statement.
The biggest direction
In March, Podimetrics made a partnership with the ALIVI Health Organization, which merged Smartmat technology in its wallet of specialized advantages to enhance its quality advantages for health plans and motivations.
In 2024, Podimetrics filed a lawsuit against Bliedrop Medical in Ireland to violate patents. Bliedrop It contains a device that allows a person with diabetes to wipe his feet for potential footsteps of foot ulcers.
According to The compatible, Bliedrop claims directly “and/or through subsidiary companies, employees, intermediaries, or commercial names” committed to violations acts through import, offer to sell and sell a tool that violates [Podimetrics] Patents in the lawsuit. “The case was rejected after podmetrics pulled her demand.
In 2022, Podimetrics recorded 45 million dollars in the Capital Financing Tour C. The capital was used to expand the development teams and research of Podimetrics in addition to increasing the number of services provided by their nurses support teams.
In 2019, podimmetrics was raised 13.4 million dollars in financing from the series B. Rock Health and Norwich Ventures and Development of Scientific Health participated in the tour.
Other companies include diabetes space Dexcom, in 2024, investigated a $ 75 million strategic investment in the Oraa health tracking maker and established a strategic partnership to enable the dual -direction data flow between continuous glucose monitoring in Dexcom (CGM) and the ORA episode. Dexcom’s investment of $ 75 million raised OURA to more than $ 5 billion.
Diabetes and insulin software management company Glytec and Pharmaceutical Roche joined last year to allow the Glytec program to be used in relation to the Roch from Roch Hospital from the Glucose at the Roch Hospital in the United States and global markets.
According to Roche, the architectural engineering of the Cobas Pulse provides a laboratory similar to the need to repeat the tests. The system can be used on all patient groups, including newborns and intensive care patients.